Table 1.
Variables | Group I – control (n=60) | Group II – LC (n=60) | Group III – HCC (n=60) | P-values | ||
---|---|---|---|---|---|---|
Age (years) | 0.533 | |||||
Range | 49–60 | 47–65 | 45–81 | I vs II | I vs III | II vs III |
Mean±SD | 53.4±5.4 | 57.8±7.4 | 59±7.8 | 0.880 | 0.360 | 0.680 |
Sex, n (%) | 0.842 | |||||
Male | 36 (60) | 42 (70) | 40 (66.7) | I vs II | I vs III | II vs III |
Female | 24 (40) | 18 (30) | 20 (33.3) | 0.690 | 0.734 | 0.794 |
Ascites, n (%) | ||||||
No | 60 (100) | 12 (20) | 5 (8.3) | – | ||
Mild | – | 15 (25) | 10 (16.7) | |||
Moderate | – | 20 (33.3) | 25 (41.7) | |||
Massive | – | 13 (21.7) | 20 (33.3) | |||
PVT, n (%) | 0 | 0 | 19 (31.7) | – | ||
Tumor size, n (%) | ||||||
<3 (cm) | 0 | 0 | 34 (56.7) | – | ||
≥3 (cm) | 0 | 0 | 26 (43.3) |
Abbreviations:HCC, hepatocellular carcinoma; LC, liver cirrhosis; PVT, portal vein thrombosis.